FI924018A0 - 1,4-dihydropyridiner med paf-antagonistisk aktivitet. - Google Patents
1,4-dihydropyridiner med paf-antagonistisk aktivitet.Info
- Publication number
- FI924018A0 FI924018A0 FI924018A FI924018A FI924018A0 FI 924018 A0 FI924018 A0 FI 924018A0 FI 924018 A FI924018 A FI 924018A FI 924018 A FI924018 A FI 924018A FI 924018 A0 FI924018 A0 FI 924018A0
- Authority
- FI
- Finland
- Prior art keywords
- dihydropyridiner
- antagonistic activities
- paf antagonistic
- paf
- activities
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3801717A DE3801717C1 (fi) | 1988-01-21 | 1988-01-21 | |
| EP91500103A EP0531598A1 (en) | 1988-01-21 | 1991-09-09 | 1,4-Dihydropyridines with paf-antagonistic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI924018A0 true FI924018A0 (fi) | 1992-09-08 |
| FI924018A FI924018A (fi) | 1993-03-10 |
Family
ID=40279084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI924018A FI924018A (fi) | 1988-01-21 | 1992-09-08 | 1,4-dihydropyridiner med paf-antagonisk aktivitet |
Country Status (19)
| Country | Link |
|---|---|
| EP (2) | EP0325187B1 (fi) |
| JP (2) | JPH01233273A (fi) |
| KR (1) | KR910008348B1 (fi) |
| AR (1) | AR248137A1 (fi) |
| BR (1) | BR9203580A (fi) |
| CA (2) | CA1332838C (fi) |
| CZ (1) | CZ278692A3 (fi) |
| DE (1) | DE3801717C1 (fi) |
| DK (1) | DK25989A (fi) |
| ES (1) | ES2052783T3 (fi) |
| FI (1) | FI924018A (fi) |
| GR (1) | GR3006934T3 (fi) |
| HU (1) | HUT65253A (fi) |
| IE (2) | IE890136L (fi) |
| MX (1) | MX9204642A (fi) |
| NO (1) | NO923489L (fi) |
| PL (1) | PL295861A1 (fi) |
| PT (2) | PT89494B (fi) |
| ZA (2) | ZA89519B (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3801717C1 (fi) * | 1988-01-21 | 1989-05-24 | Alter S.A., Madrid, Es | |
| WO1996004268A1 (fr) * | 1994-07-29 | 1996-02-15 | Nikken Chemicals Co., Ltd. | Compose de 1,4-dihydropyridine et composition medicinale contenant ledit compose |
| AU1224599A (en) * | 1997-11-14 | 1999-06-07 | Neurosearch A/S | Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction |
| US6566359B1 (en) | 2002-05-20 | 2003-05-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs |
| WO2016144995A1 (en) * | 2015-03-09 | 2016-09-15 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compositions and methods for the treatment of glioblastoma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2747513A1 (de) * | 1977-10-22 | 1979-05-03 | Bayer Ag | Dihydropyridine mit schwefelhaltigen estergruppierungen |
| US4761420A (en) * | 1986-06-13 | 1988-08-02 | Laboratoires Syntex S.A. | Antihypertensive dihydropyridine derivatives |
| DE3801717C1 (fi) * | 1988-01-21 | 1989-05-24 | Alter S.A., Madrid, Es |
-
1988
- 1988-01-21 DE DE3801717A patent/DE3801717C1/de not_active Expired
-
1989
- 1989-01-16 ES ES89100656T patent/ES2052783T3/es not_active Expired - Lifetime
- 1989-01-16 EP EP89100656A patent/EP0325187B1/en not_active Expired - Lifetime
- 1989-01-17 AR AR89312998A patent/AR248137A1/es active
- 1989-01-18 IE IE890136A patent/IE890136L/xx unknown
- 1989-01-19 CA CA000588668A patent/CA1332838C/en not_active Expired - Fee Related
- 1989-01-20 PT PT89494A patent/PT89494B/pt not_active IP Right Cessation
- 1989-01-20 JP JP1013011A patent/JPH01233273A/ja active Granted
- 1989-01-20 DK DK025989A patent/DK25989A/da not_active Application Discontinuation
- 1989-01-21 KR KR1019890000654A patent/KR910008348B1/ko not_active IP Right Cessation
- 1989-01-23 ZA ZA89519A patent/ZA89519B/xx unknown
-
1991
- 1991-09-09 EP EP91500103A patent/EP0531598A1/en not_active Withdrawn
-
1992
- 1992-07-22 CA CA002074419A patent/CA2074419A1/en not_active Abandoned
- 1992-07-24 IE IE241292A patent/IE922412A1/en not_active Application Discontinuation
- 1992-07-29 ZA ZA925692A patent/ZA925692B/xx unknown
- 1992-08-11 MX MX9204642A patent/MX9204642A/es unknown
- 1992-08-27 JP JP4228409A patent/JPH0742271B2/ja not_active Expired - Lifetime
- 1992-09-08 HU HU9202873A patent/HUT65253A/hu unknown
- 1992-09-08 PT PT100848A patent/PT100848A/pt not_active Application Discontinuation
- 1992-09-08 PL PL29586192A patent/PL295861A1/xx unknown
- 1992-09-08 FI FI924018A patent/FI924018A/fi not_active Application Discontinuation
- 1992-09-08 NO NO92923489A patent/NO923489L/no unknown
- 1992-09-09 BR BR929203580A patent/BR9203580A/pt not_active Application Discontinuation
- 1992-09-09 CZ CS922786A patent/CZ278692A3/cs unknown
-
1993
- 1993-01-28 GR GR930400181T patent/GR3006934T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR890011842A (ko) | 1989-08-22 |
| NO923489L (no) | 1993-03-10 |
| CA2074419A1 (en) | 1993-03-10 |
| IE890136L (en) | 1989-07-21 |
| EP0531598A1 (en) | 1993-03-17 |
| DE3801717C1 (fi) | 1989-05-24 |
| ES2052783T3 (es) | 1994-07-16 |
| DK25989D0 (da) | 1989-01-20 |
| FI924018A (fi) | 1993-03-10 |
| EP0325187B1 (en) | 1992-11-11 |
| KR910008348B1 (ko) | 1991-10-12 |
| GR3006934T3 (fi) | 1993-06-30 |
| ZA89519B (en) | 1989-10-25 |
| PT89494B (pt) | 1994-03-31 |
| JPH0552827B2 (fi) | 1993-08-06 |
| JPH0742271B2 (ja) | 1995-05-10 |
| BR9203580A (pt) | 1993-04-13 |
| PT89494A (pt) | 1989-10-04 |
| HUT65253A (en) | 1994-05-02 |
| MX9204642A (es) | 1993-12-01 |
| EP0325187A1 (en) | 1989-07-26 |
| HU9202873D0 (en) | 1992-11-30 |
| CA1332838C (en) | 1994-11-01 |
| AR248137A1 (es) | 1995-06-30 |
| PL295861A1 (en) | 1993-05-04 |
| JPH01233273A (ja) | 1989-09-19 |
| PT100848A (pt) | 1993-10-29 |
| JPH05208958A (ja) | 1993-08-20 |
| CZ278692A3 (en) | 1993-12-15 |
| IE922412A1 (en) | 1993-03-10 |
| ZA925692B (en) | 1993-03-02 |
| DK25989A (da) | 1989-07-22 |
| NO923489D0 (no) | 1992-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI916165A0 (fi) | 1,3-oxatiolannukleosidanaloger. | |
| DE3764686D1 (de) | N,n'-dihalo-2-imidazolidinone. | |
| NO900619L (no) | Substituerte 1,3-okstiolaner. | |
| FI920674A0 (fi) | Laogkalorihaltiga, graeddaktiga naeringsprodukter med mjuka organoleptiska egenskaper. | |
| FI905500A0 (fi) | Individualiserade, med polykarboxylsyra tvaerbundna fibrer. | |
| FI896128A0 (fi) | Slang- eller roerformig, elastisk hylsa med mikrobicida egenskaper foer urinroerkatetrar. | |
| DE3783669T2 (de) | Alpha-aryl-alpha-phenethyl-1h-1,2,4-triazol-1-propan-nitrile. | |
| FI892534A (fi) | Foerfarande foer framstaellning av 1,3-dioler av epoxider. | |
| FI892874A0 (fi) | Flera laegen intagande, vikbar laenstol med justerbar ryggstoedlutning och sitshoejd. | |
| FI875619A (fi) | 6-benzoxazinyl- och 6-benzotiazonyl-2,3,4,5-tetrahydropyridazin-3-oner. | |
| FI910033A0 (fi) | Laogmaettat, plastiskt universalfett med speciellt hydrogenerad delvis smaeltande fettkomponent. | |
| FI892387A (fi) | Mellanprodukter foer framstaellning av 1,4-dihydro-4-oxokinolin-3-karboxylsyraestrar. | |
| FI890501A (fi) | Aminosyraamider med psykotropisk verkan, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning. | |
| DE58900454D1 (de) | Gleitstueck. | |
| FI880552A (fi) | Substituerade 2,6-substituerade pyridinfoereningar. | |
| FI881829A0 (fi) | 1,3-dioxaner. | |
| FI924018A0 (fi) | 1,4-dihydropyridiner med paf-antagonistisk aktivitet. | |
| FI894455A (fi) | 1,4-dihydropyridinderivat. | |
| DE59008914D1 (de) | Pyridyl-methylenamino-1,2,4-triazinone. | |
| FI890483A0 (fi) | Foerfarande foer framstaellning av sulfaterade alkanol- eller alkylfenoloxetylater med saenkt 1,4-dioxanhalt. | |
| ES2015605B3 (es) | 3,4-dihidro-2h-piranos. | |
| DE271425T1 (de) | Multimetallisch hergestellter gegenstand. | |
| FI880081A0 (fi) | 2,1-bensotiazepin-2,2-dioxid-5 -karboxylsyraderivat. | |
| FI903774A0 (fi) | Ogarvade, biologiskt stabila skinn i fuktig form. | |
| FI922856A0 (fi) | Med mikrovaogor fungerande resonans- haolrum, uppvisande en dielektrisk dubbelresonator och med en trimbar resonansfrekvens. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |